封面
市場調查報告書
商品編碼
2179102

醫療保健聯合學習平台市場預測至2034年-全球分析(按組件、平台類型、技術、應用、最終用戶和地區分類)

Federated Learning Platforms for Healthcare Market Forecasts to 2034 - Global Analysis By Component (Software, Hardware and Services), Platform Type, Technology, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 300+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球醫療保健聯邦學習平台市場規模將達到 13 億美元,在預測期內以 21.6% 的複合年成長率成長,到 2034 年將達到 62 億美元。

醫療聯邦學習平台市場涵蓋了隱私保護型人工智慧平台,這些平台支援醫院、研究機構和醫療組織之間的協作模型學習,而無需集中儲存高度敏感的患者資料。對安全醫療資料共享日益成長的需求、人工智慧的廣泛應用以及日益嚴格的資料隱私法規正在推動市場成長。分散式機器學習、安全聚合和敏感運算技術的進步正在提升互通性和分析能力。精準醫療和協作醫學研究投入的增加也創造了更多機會。

對保護隱私的醫療人工智慧和安全資料共享的需求日益成長。

對保護隱私的醫療人工智慧和安全資料共享日益成長的需求正在推動市場成長。醫療機構正在採用聯邦學習平台,在分散式資料集上開發智慧模型,而無需將敏感的患者記錄傳輸到集中式儲存庫。醫學影像人工智慧、臨床分析和精準醫療的廣泛應用正在加速協作式機器學習的發展。資料保護條例和組織管治要求進一步加劇了這項需求。安全聚合、加密計算和分散式模型訓練技術的進步正在提昇平台的功能。醫療保健領域不斷推進的數位化進程正在促進更廣泛的應用。

複雜的技術整合和醫療資料互通性

複雜的技術整合和醫療保健數據互通性正在阻礙市場成長。實施聯邦學習平台需要資訊系統、資料結構和運算能力各異的醫療機構之間進行協調。臨床數據品質和患者群體的差異會降低模型效能並使訓練複雜化。高昂的實施成本、網路安全要求和技術專長不足也帶來了進一步的挑戰。建立可靠的管治框架和管理分散式基礎設施增加了營運的複雜性。小規模的醫療機構在實施過程中可能面臨財務和技術方面的障礙。

共同進行醫療人工智慧研究,並擴展聯邦精準醫療平台

醫療人工智慧領域的合作研究以及聯邦精準醫療平台的擴展帶來了巨大的成長機會。醫院、製藥公司和研究機構正在投資分散式機器學習,以分析醫學影像、基因組資訊和臨床訊息,同時保持組織的數據控制權。聯邦學習支持多中心合作研發,並支持開發基於更多樣化患者群體訓練的模型。隨著保密運算、差分隱私和基於雲端的編配的日益融合,合作也得到了加強。醫療服務提供者、科技公司和研究機構之間的夥伴關係可望加速這些技術的應用。

聯邦人工智慧模型的隱私洩漏風險和可靠性方面的不確定性

隱私外洩風險和聯邦人工智慧模型可靠性的不確定性對市場發展構成重大挑戰。雖然聯邦學習減少了集中共用患者資料的需求,但如果缺乏充分的安全保障措施,模型更新可能會洩露敏感資訊。分散式訓練系統可能受到惡意參與者、資料投毒和網路安全漏洞的攻擊。不同機構間資料集的差異會影響模型的準確性和泛化能力。不斷變化的隱私法規以及圍繞共同開發人工智慧模型課責的不確定性也帶來了進一步的挑戰。安全分析技術之間日益激烈的競爭可能會影響其應用趨勢。

新型冠狀病毒(COVID-19)的影響:

新冠疫情凸顯了醫療機構間進行合作研究和安全交換分析成果的重要性。對疾病預測、醫學影像分析和人群健康監測的需求激增,推動了人們對隱私保護型機器學習的興趣。儘管臨床實踐和研究活動受到限制,為實施帶來了挑戰,但遠距合作研究進一步提升了分散式人工智慧技術的重要性。聯邦學習為利用地理位置分散的資料集開發模型提供了契機,而無需集中管理病患資訊。疫情後對醫療人工智慧的投資將持續推動市場發展。

在預測期內,軟體領域預計將佔據最大的市場佔有率。

對聯邦編配、分散式模型學習和隱私保護型醫療分析日益成長的需求預計將推動軟體領域在預測期內佔據最大的市場佔有率。軟體平台協調參與機構間的AI開發,同時支援安全的資料聚合和資料管治要求。協作式醫學影像、臨床研究和預測分析的日益普及正在推動這一需求。雲端原生架構、加密運算和自動化模型管理的進步正在增強平台的功能。醫療AI舉措的擴展進一步推動了軟體領域的成長。

預計在預測期內,機密運算和可信任執行環境區隔市場將呈現最高的複合年成長率。

在預測期內,受安全分散式人工智慧運算需求成長以及對高度敏感醫療資訊保護的迫切需求驅動,機密運算和可信任執行環境細分市場預計將呈現最高的成長率。機密運算技術將資料處理隔離在受保護的執行環境中,從而降低協同模型訓練過程中資訊外洩的風險。與雲端基礎設施和隱私保護分析平台的整合不斷推進,正在促進其應用。硬體安全、加密處理和可信任運算架構的進步有望加速該細分市場的成長。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其先進的醫療保健IT基礎設施、在人工智慧領域的大量投資以及對安全臨床數據共享的強勁需求。聯邦學習正透過研究夥伴關係、醫學影像舉措以及隱私保護分析技術的開發,在美國和加拿大蓬勃發展。雲端運算和人工智慧驅動的醫療保健平台的日益普及正在推動該地區的市場成長。醫院、科技公司、製藥公司和學術機構之間的合作進一步鞏固了北美的市場地位。

複合年成長率最高的地區:

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於醫療數位化進程的推進、人工智慧投資的增加以及對安全、多中心協作醫學研究日益成長的需求。協作醫療分析和分散式機器學習計畫正在中國、印度、日本、韓國和澳洲穩步推進。政府支持的數位醫療計畫和不斷擴展的研究基礎設施正在加速技術的應用。雲端運算、隱私保護型人工智慧以及醫療資料互通性預計將進一步推動該地區的市場成長。

免費客製化服務:

所有購買此報告的客戶均可選擇以下免費自訂選項之一:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域分類
    • 根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章:執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球醫療保健聯邦學習平台市場:按組件分類

  • 軟體
    • 聯邦學習編配軟體
    • 模型學習與聚合軟體
    • 隱私保護型資料分析軟體
  • 硬體
    • 邊緣運算和處理系統
    • 安全運算基礎設施
  • 服務
    • 平台整合與部署服務
    • 諮詢與資料管治服務
    • 維護和技術支援服務

第6章 全球醫療保健聯邦學習平台市場:依平台類型分類

  • 機構間聯合學習平台
  • 聯邦醫學影像平台
  • 聯合臨床數據分析平台
  • 聯合基因組學和多體學平台
  • 聯合藥物發現與研究平台
  • 聯邦人工智慧模型開發平台
  • 其他平台類型

第7章 全球醫療保健聯邦學習平台市場:依技術分類

  • 水平聯邦學習
  • 垂直聯邦學習
  • 聯邦遷移學習
  • 安全聚合和多方計算
  • 差分隱私
  • 同構加密
  • 機密運算和可信任執行環境
  • 其他技術

第8章 全球醫療保健聯邦學習平台市場:按應用分類

  • 醫學影像和診斷人工智慧
  • 臨床決策支援與預測分析
  • 藥物發現與開發
  • 基因組學與精準醫學
  • 臨床試驗與真實世界數據
  • 公共衛生管理和疾病監測
  • 電子健康記錄 (EHR) 分析
  • 其他用途

第9章 全球醫療保健聯邦學習平台市場:以最終用戶分類

  • 醫院和醫療保健機構
  • 製藥和生物技術公司
  • 學術和研究機構
  • 臨床研究機構
  • 健康保險提供者和保險公司
  • 政府和公共衛生組織
  • 其他最終用戶

第10章 全球醫療保健聯邦學習平台市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章:公司簡介

  • NVIDIA Corporation
  • Owkin
  • Rhino Health, Inc.
  • Flower Labs GmbH
  • Intel Corporation
  • Apheris GmbH
  • BeeKeeperAI, Inc.
  • Lifebit Biotech Ltd.
  • Duality Technologies, Inc.
  • Tune Insight SA
  • OASYS NOW
  • Microsoft Corporation
  • Amazon Web Services, Inc.
  • Google LLC
  • IBM Corporation
  • Hewlett Packard Enterprise Company
  • Sherpa.ai
  • OpenMined
Product Code: SMRC41263

According to Stratistics MRC, the Global Federated Learning Platforms for Healthcare Market is accounted for $1.3 billion in 2026 and is expected to reach $6.2 billion by 2034 growing at a CAGR of 21.6% during the forecast period. The Federated Learning Platforms for Healthcare Market encompasses privacy-preserving artificial intelligence platforms that enable collaborative model training across hospitals, research institutions, and healthcare organizations without centralizing sensitive patient data. Increasing demand for secure healthcare data collaboration, expanding AI adoption, and stringent data privacy regulations are supporting market growth. Advancements in distributed machine learning, secure aggregation, and confidential computing improve interoperability and analytical capabilities. Growing investment in precision medicine and collaborative healthcare research creates additional opportunities.

Market Dynamics:

Driver:

Increasing demand for privacy-preserving healthcare AI and secure data collaboration

Increasing demand for privacy-preserving healthcare AI and secure data collaboration is driving market growth. Healthcare organizations are adopting federated learning platforms to develop intelligent models across distributed datasets without transferring sensitive patient records to centralized repositories. Growing adoption of medical imaging AI, clinical analytics, and precision medicine encourages collaborative machine learning. Data protection regulations and institutional governance requirements further strengthen demand. Advancements in secure aggregation, encrypted computation, and distributed model training improve platform capabilities. Expanding healthcare digitalization initiatives support broader implementation.

Restraint:

Complex technical integration and inconsistent healthcare data interoperability

Complex technical integration and inconsistent healthcare data interoperability restrain market growth. Federated learning platforms require coordination across healthcare institutions with different information systems, data structures, and computing capabilities. Variations in clinical data quality and patient populations may reduce model performance and complicate training. High implementation costs, cybersecurity requirements, and limited technical expertise create additional challenges. Establishing reliable governance frameworks and managing distributed infrastructure increase operational complexity. Smaller healthcare providers may face financial and technological barriers to adoption.

Opportunity:

Expansion of collaborative medical AI research and federated precision medicine platforms

Expansion of collaborative medical AI research and federated precision medicine platforms presents significant growth opportunities. Hospitals, pharmaceutical companies, and research institutions are investing in distributed machine learning to analyze medical imaging, genomics, and clinical information while maintaining institutional data control. Federated learning supports multicenter research and development of models trained on more diverse patient populations. Growing integration of confidential computing, differential privacy, and cloud-based orchestration improves collaboration. Partnerships among healthcare providers, technology companies, and research organizations are expected to accelerate adoption.

Threat:

Privacy leakage risks and uncertainty in federated AI model reliability

Privacy leakage risks and uncertainty in federated AI model reliability pose significant challenges to market development. Although federated learning reduces the need for centralized patient data sharing, model updates can still expose sensitive information without appropriate safeguards. Malicious participants, data poisoning, and cybersecurity vulnerabilities may compromise distributed training systems. Differences in institutional datasets can affect model accuracy and generalizability. Evolving privacy regulations and uncertainty surrounding accountability for collaborative AI models create additional challenges. Increasing competition among secure analytics technologies may influence adoption.

Covid-19 Impact:

The COVID-19 pandemic highlighted the importance of collaborative healthcare research and secure exchange of analytical insights across medical institutions. Growing demand for disease prediction, medical imaging analysis, and population health monitoring encouraged interest in privacy-preserving machine learning. Restrictions on clinical operations and research activities created implementation challenges, while remote collaboration increased the relevance of distributed AI technologies. Federated learning offered opportunities to develop models using geographically dispersed datasets without centralizing patient information. Post-pandemic investment in healthcare AI continues to support market development.

The software segment is expected to be the largest during the forecast period

The software segment is expected to account for the largest market share during the forecast period due to increasing demand for federated learning orchestration, distributed model training, and privacy-preserving healthcare analytics. Software platforms coordinate AI development across participating institutions while supporting secure aggregation and data governance requirements. Growing adoption of collaborative medical imaging, clinical research, and predictive analytics encourages demand. Advancements in cloud-native architectures, encrypted computation, and automated model management improve platform capabilities. Expanding healthcare AI initiatives further strengthen software segment growth.

The confidential computing & trusted execution environments segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the confidential computing & trusted execution environments segment is predicted to witness the highest growth rate due to increasing demand for secure distributed AI computation and protection of sensitive healthcare information. Confidential computing technologies isolate data processing within protected execution environments, helping reduce exposure during collaborative model training. Growing integration with cloud infrastructure and privacy-preserving analytics platforms encourages adoption. Advancements in hardware-based security, encrypted processing, and trusted computing architectures are expected to accelerate segment growth.

Region with largest share:

During the forecast period, North America is expected to hold the largest market share due to advanced healthcare IT infrastructure, significant investment in artificial intelligence, and strong demand for secure clinical data collaboration. The United States and Canada are advancing federated learning through research partnerships, medical imaging initiatives, and privacy-preserving analytics development. Growing adoption of cloud computing and AI-enabled healthcare platforms encourages regional market expansion. Collaboration among hospitals, technology companies, pharmaceutical organizations, and academic institutions further strengthens North America's position.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding healthcare digitalization, increasing investment in artificial intelligence, and growing demand for secure multicenter medical research. China, India, Japan, South Korea, and Australia are advancing collaborative healthcare analytics and distributed machine learning initiatives. Government-supported digital health programs and expanding research infrastructure encourage technology adoption. Improvements in cloud computing, privacy-preserving AI, and healthcare data interoperability are expected to accelerate regional market growth.

Key players in the market

Some of the key players in the Federated Learning Platforms for Healthcare Market include NVIDIA Corporation, Owkin, Rhino Health, Inc., Flower Labs GmbH, Intel Corporation, Apheris GmbH, BeeKeeperAI, Inc., Lifebit Biotech Ltd., Duality Technologies, Inc., Tune Insight SA, OASYS NOW, Microsoft Corporation, Amazon Web Services, Inc., Google LLC, IBM Corporation, Hewlett Packard Enterprise Company, Sherpa.ai, and OpenMined.

Key Developments:

In October 2026, Rhino Health, Inc., operating as Rhino Federated Computing, introduced Trusted Integrations and Workflows for its federated computing platform. The capabilities are designed to connect privacy-preserving AI projects with enterprise technology systems, improve workflow repeatability, and support deployment of federated analytics across distributed healthcare and life sciences environments.

In September 2026, Owkin announced a partnership with Estonia to advance sovereign AI in biology. The initiative focuses on developing AI capabilities that support biomedical research while maintaining national control over sensitive health information and strengthening secure, collaborative data-driven discovery.

In September 2026, NVIDIA Corporation supported discussions on clinical deployment of federated learning at NVIDIA FLARE Day 2026. Presentations included the National Cancer Institute's FLAIMME initiative, which uses NVIDIA FLARE to enable collaborative AI development across cancer centers while maintaining local control over patient data.

Components Covered:

  • Software
  • Hardware
  • Services

Platform Types Covered:

  • Cross-Institutional Federated Learning Platforms
  • Federated Medical Imaging Platforms
  • Federated Clinical Data Analytics Platforms
  • Federated Genomics & Multi-Omics Platforms
  • Federated Drug Discovery & Research Platforms
  • Federated AI Model Development Platforms
  • Other Platform Types

Technologies Covered:

  • Horizontal Federated Learning
  • Vertical Federated Learning
  • Federated Transfer Learning
  • Secure Aggregation & Multiparty Computation
  • Differential Privacy
  • Homomorphic Encryption
  • Confidential Computing & Trusted Execution Environments
  • Other Technologies

Applications Covered:

  • Medical Imaging & Diagnostic AI
  • Clinical Decision Support & Predictive Analytics
  • Drug Discovery & Development
  • Genomics & Precision Medicine
  • Clinical Trials & Real-World Evidence
  • Population Health & Disease Surveillance
  • Electronic Health Record Analytics
  • Other Applications

End Users Covered:

  • Hospitals & Healthcare Providers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Clinical Research Organizations
  • Healthcare Payers & Insurance Providers
  • Government & Public Health Organizations
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Federated Learning Platforms for Healthcare Market, By Component

  • 5.1 Software
    • 5.1.1 Federated Learning Orchestration Software
    • 5.1.2 Model Training & Aggregation Software
    • 5.1.3 Privacy-Preserving Data Analytics Software
  • 5.2 Hardware
    • 5.2.1 Edge Computing & Processing Systems
    • 5.2.2 Secure Computing Infrastructure
  • 5.3 Services
    • 5.3.1 Platform Integration & Implementation Services
    • 5.3.2 Consulting & Data Governance Services
    • 5.3.3 Maintenance & Technical Support Services

6 Global Federated Learning Platforms for Healthcare Market, By Platform Type

  • 6.1 Cross-Institutional Federated Learning Platforms
  • 6.2 Federated Medical Imaging Platforms
  • 6.3 Federated Clinical Data Analytics Platforms
  • 6.4 Federated Genomics & Multi-Omics Platforms
  • 6.5 Federated Drug Discovery & Research Platforms
  • 6.6 Federated AI Model Development Platforms
  • 6.7 Other Platform Types

7 Global Federated Learning Platforms for Healthcare Market, By Technology

  • 7.1 Horizontal Federated Learning
  • 7.2 Vertical Federated Learning
  • 7.3 Federated Transfer Learning
  • 7.4 Secure Aggregation & Multiparty Computation
  • 7.5 Differential Privacy
  • 7.6 Homomorphic Encryption
  • 7.7 Confidential Computing & Trusted Execution Environments
  • 7.8 Other Technologies

8 Global Federated Learning Platforms for Healthcare Market, By Application

  • 8.1 Medical Imaging & Diagnostic AI
  • 8.2 Clinical Decision Support & Predictive Analytics
  • 8.3 Drug Discovery & Development
  • 8.4 Genomics & Precision Medicine
  • 8.5 Clinical Trials & Real-World Evidence
  • 8.6 Population Health & Disease Surveillance
  • 8.7 Electronic Health Record Analytics
  • 8.8 Other Applications

9 Global Federated Learning Platforms for Healthcare Market, By End User

  • 9.1 Hospitals & Healthcare Providers
  • 9.2 Pharmaceutical & Biotechnology Companies
  • 9.3 Academic & Research Institutions
  • 9.4 Clinical Research Organizations
  • 9.5 Healthcare Payers & Insurance Providers
  • 9.6 Government & Public Health Organizations
  • 9.7 Other End Users

10 Global Federated Learning Platforms for Healthcare Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 NVIDIA Corporation
  • 13.2 Owkin
  • 13.3 Rhino Health, Inc.
  • 13.4 Flower Labs GmbH
  • 13.5 Intel Corporation
  • 13.6 Apheris GmbH
  • 13.7 BeeKeeperAI, Inc.
  • 13.8 Lifebit Biotech Ltd.
  • 13.9 Duality Technologies, Inc.
  • 13.10 Tune Insight SA
  • 13.11 OASYS NOW
  • 13.12 Microsoft Corporation
  • 13.13 Amazon Web Services, Inc.
  • 13.14 Google LLC
  • 13.15 IBM Corporation
  • 13.16 Hewlett Packard Enterprise Company
  • 13.17 Sherpa.ai
  • 13.18 OpenMined

List of Tables

  • Table 1 Global Federated Learning Platforms for Healthcare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Federated Learning Platforms for Healthcare Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Federated Learning Platforms for Healthcare Market Outlook, By Software (2023-2034) ($MN)
  • Table 4 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Learning Orchestration Software (2023-2034) ($MN)
  • Table 5 Global Federated Learning Platforms for Healthcare Market Outlook, By Model Training & Aggregation Software (2023-2034) ($MN)
  • Table 6 Global Federated Learning Platforms for Healthcare Market Outlook, By Privacy-Preserving Data Analytics Software (2023-2034) ($MN)
  • Table 7 Global Federated Learning Platforms for Healthcare Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 8 Global Federated Learning Platforms for Healthcare Market Outlook, By Edge Computing & Processing Systems (2023-2034) ($MN)
  • Table 9 Global Federated Learning Platforms for Healthcare Market Outlook, By Secure Computing Infrastructure (2023-2034) ($MN)
  • Table 10 Global Federated Learning Platforms for Healthcare Market Outlook, By Services (2023-2034) ($MN)
  • Table 11 Global Federated Learning Platforms for Healthcare Market Outlook, By Platform Integration & Implementation Services (2023-2034) ($MN)
  • Table 12 Global Federated Learning Platforms for Healthcare Market Outlook, By Consulting & Data Governance Services (2023-2034) ($MN)
  • Table 13 Global Federated Learning Platforms for Healthcare Market Outlook, By Maintenance & Technical Support Services (2023-2034) ($MN)
  • Table 14 Global Federated Learning Platforms for Healthcare Market Outlook, By Platform Type (2023-2034) ($MN)
  • Table 15 Global Federated Learning Platforms for Healthcare Market Outlook, By Cross-Institutional Federated Learning Platforms (2023-2034) ($MN)
  • Table 16 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Medical Imaging Platforms (2023-2034) ($MN)
  • Table 17 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Clinical Data Analytics Platforms (2023-2034) ($MN)
  • Table 18 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Genomics & Multi-Omics Platforms (2023-2034) ($MN)
  • Table 19 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Drug Discovery & Research Platforms (2023-2034) ($MN)
  • Table 20 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated AI Model Development Platforms (2023-2034) ($MN)
  • Table 21 Global Federated Learning Platforms for Healthcare Market Outlook, By Other Platform Types (2023-2034) ($MN)
  • Table 22 Global Federated Learning Platforms for Healthcare Market Outlook, By Technology (2023-2034) ($MN)
  • Table 23 Global Federated Learning Platforms for Healthcare Market Outlook, By Horizontal Federated Learning (2023-2034) ($MN)
  • Table 24 Global Federated Learning Platforms for Healthcare Market Outlook, By Vertical Federated Learning (2023-2034) ($MN)
  • Table 25 Global Federated Learning Platforms for Healthcare Market Outlook, By Federated Transfer Learning (2023-2034) ($MN)
  • Table 26 Global Federated Learning Platforms for Healthcare Market Outlook, By Secure Aggregation & Multiparty Computation (2023-2034) ($MN)
  • Table 27 Global Federated Learning Platforms for Healthcare Market Outlook, By Differential Privacy (2023-2034) ($MN)
  • Table 28 Global Federated Learning Platforms for Healthcare Market Outlook, By Homomorphic Encryption (2023-2034) ($MN)
  • Table 29 Global Federated Learning Platforms for Healthcare Market Outlook, By Confidential Computing & Trusted Execution Environments (2023-2034) ($MN)
  • Table 30 Global Federated Learning Platforms for Healthcare Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 31 Global Federated Learning Platforms for Healthcare Market Outlook, By Application (2023-2034) ($MN)
  • Table 32 Global Federated Learning Platforms for Healthcare Market Outlook, By Medical Imaging & Diagnostic AI (2023-2034) ($MN)
  • Table 33 Global Federated Learning Platforms for Healthcare Market Outlook, By Clinical Decision Support & Predictive Analytics (2023-2034) ($MN)
  • Table 34 Global Federated Learning Platforms for Healthcare Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 35 Global Federated Learning Platforms for Healthcare Market Outlook, By Genomics & Precision Medicine (2023-2034) ($MN)
  • Table 36 Global Federated Learning Platforms for Healthcare Market Outlook, By Clinical Trials & Real-World Evidence (2023-2034) ($MN)
  • Table 37 Global Federated Learning Platforms for Healthcare Market Outlook, By Population Health & Disease Surveillance (2023-2034) ($MN)
  • Table 38 Global Federated Learning Platforms for Healthcare Market Outlook, By Electronic Health Record Analytics (2023-2034) ($MN)
  • Table 39 Global Federated Learning Platforms for Healthcare Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 40 Global Federated Learning Platforms for Healthcare Market Outlook, By End User (2023-2034) ($MN)
  • Table 41 Global Federated Learning Platforms for Healthcare Market Outlook, By Hospitals & Healthcare Providers (2023-2034) ($MN)
  • Table 42 Global Federated Learning Platforms for Healthcare Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 43 Global Federated Learning Platforms for Healthcare Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
  • Table 44 Global Federated Learning Platforms for Healthcare Market Outlook, By Clinical Research Organizations (2023-2034) ($MN)
  • Table 45 Global Federated Learning Platforms for Healthcare Market Outlook, By Healthcare Payers & Insurance Providers (2023-2034) ($MN)
  • Table 46 Global Federated Learning Platforms for Healthcare Market Outlook, By Government & Public Health Organizations (2023-2034) ($MN)
  • Table 47 Global Federated Learning Platforms for Healthcare Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.